{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:30:31Z","timestamp":1793406631539,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.diagmicrobio.2025.117035","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:50:43Z","timestamp":1753944643000},"page":"117035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Carriage and infections by multi-carbapenemases producing Enterobacterales"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-2716","authenticated-orcid":false,"given":"Matteo","family":"Boattini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0001","unstructured":"https:\/\/iris.who.int\/bitstream\/handle\/10665\/376776\/9789240093461-eng.pdf?sequence=1. Last accessed on 2025 March 9th."},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapenemases in gram-negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0003","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: The impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0004","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-025-05080-1","article-title":"In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-\u03b2-lactamase producers","author":"Boattini","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0006","doi-asserted-by":"crossref","first-page":"14132","DOI":"10.3390\/cimb46120846","article-title":"Updates on the activity, efficacy and emerging mechanisms of resistance to cefiderocol","volume":"46","author":"Bianco","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0007","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0008","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10096-015-2379-9","article-title":"Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade","volume":"34","author":"Meletis","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00008-24","article-title":"Global emergence of double and multi-carbapenemase producing organisms: epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence","volume":"12","author":"Yuan","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0010","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/ash.2022.6","article-title":"Emergence of dual and multicarbapenemase coproducing organisms in the United States","volume":"2","author":"Tadese","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0011","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10096-022-04408-5","article-title":"Occurrence of multi-carbapenemases producers among carbapenemase-producing enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era","volume":"41","author":"Bianco","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01205-24","article-title":"Multispecies emergence of dual blaKPC\/NDM carbapenemase-producing enterobacterales recovered from invasive infections in Chile","volume":"69","author":"Quesille-Villalobos","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0013","article-title":"An outbreak of double carbapenemase-producing Klebsiella pneumoniae, harbouring NDM-5 and OXA-48 genes, at a tertiary hospital in Canberra, Australia","volume":"48","author":"Mhango","year":"2024","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0014","doi-asserted-by":"crossref","first-page":"dlad137","DOI":"10.1093\/jacamr\/dlad137","article-title":"Clinical, microbiological and genomic characterization of gram-negative bacteria with dual carbapenemases as identified by rapid molecular testing","volume":"6","author":"Mushtaq","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0015","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/microorganisms11071717","article-title":"Clinical and genomic characterization of carbapenem-resistant Klebsiella pneumoniae with concurrent production of NDM and OXA-48-like carbapenemases in Southern California, 2016-2022","volume":"11","author":"Cer\u00f3n","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0016","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.26633\/RPSP.2020.50","article-title":"Characteristics of dual carbapenemase-producing Klebsiella pneumoniae strains from an outbreak in Venezuela: a retrospective study","volume":"44","author":"Mart\u00ednez","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jgar.2024.06.012","article-title":"Occurrence of multi-carbapenemase-producing enterobacterales in a tertiary hospital in Madrid (Spain): A new epidemiologic scenario","volume":"38","author":"Cabello","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1556\/030.2024.02464","article-title":"NDM-1 and KPC-3 co-producing Klebsiella pneumoniae ST512 in bronchial secretion from a patient in an intensive care unit of a Greek Tertiary Care Hospital","volume":"71","author":"Chatzidimitriou","year":"2024","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01462-24","article-title":"Double carbapenemases in Klebsiella pneumoniae blood isolates: dissemination in a single medical center via multiple plasmids and a variety of highly efficient clones","volume":"69","author":"Rigatou","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03305-23","article-title":"In-depth characterization of multidrug-resistant NDM-1 and KPC-3 co-producing Klebsiella pneumoniae bloodstream isolates from Italian hospital patients","volume":"12","author":"Posteraro","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0021","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.2147\/IDR.S474150","article-title":"In vitro synergistic and bactericidal effects of Aztreonam in combination with Ceftazidime\/Avibactam, Meropenem\/Vaborbactam and Imipenem\/Relebactam against dual-carbapenemase-producing enterobacterales","volume":"17","author":"Fu","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0022","article-title":"Antimicrobial activities of aztreonam-avibactam and comparator agents against contemporary (2016) clinical Enterobacteriaceae isolates","volume":"62","author":"Sader","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00472-17","article-title":"In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015","volume":"61","author":"Karlowsky","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0024","doi-asserted-by":"crossref","first-page":"e00414","DOI":"10.1128\/AAC.00414-18","article-title":"Aztreonam-avibactam combination restores susceptibility of Aztreonam in dual-carbapenemase-producing Enterobacteriaceae","volume":"62","author":"Chew","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117035_bib0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10096-024-04745-7","volume":"43","author":"Bianco","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0026","series-title":"Guidance document on broth microdilution testing of cefiderocol","year":"2024"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0027","unstructured":"Available at https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_15.0_Breakpoint_Tables.pdf. Last accessed 2025 March 10th."},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0028","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.42.2300522","article-title":"Rapid spread of a novel NDM-producing clone of Klebsiella pneumoniae CC147, Northern Italy, February to August 2023","volume":"28","author":"Mileto","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jgar.2024.01.015","article-title":"Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy)","volume":"36","author":"Loconsole","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0030","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3201\/eid2709.210456","article-title":"Gram-negative bacteria harboring multiple carbapenemase genes, United States, 2012-2019","volume":"27","author":"Ham","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107115","article-title":"Enterobacterales carrying chromosomal AmpC \u03b2-lactamases in Europe (EuESCPM): epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020-2022","volume":"63","author":"Boattini","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0032","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110649","article-title":"Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults","volume":"39","author":"Anthony","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0034","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1128\/AAC.00431-09","article-title":"Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study","volume":"53","author":"Tacconelli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10096-023-04577-x","article-title":"Rapid diagnostics and ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy","volume":"42","author":"Boattini","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0036","first-page":"dkaf161","article-title":"Aztreonam\/avibactam activity against enterobacterales from European medical centres: summary of 5\u2005years of surveillance prior to approval for clinical use (2019-2023)","author":"Sader","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0037","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0038","doi-asserted-by":"crossref","unstructured":"Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS et al. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 202;21:213-25. doi: 10.1016\/S1473-3099(20)30731-3.","DOI":"10.1016\/S1473-3099(20)30731-3"},{"key":"10.1016\/j.diagmicrobio.2025.117035_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkae367","article-title":"Resistance profiles of carbapenemase-producing enterobacterales in a large centre in England: are we already losing cefiderocol?","volume":"80","author":"Baltas","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932500358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932500358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:22:08Z","timestamp":1756398128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288932500358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S073288932500358X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117035","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carriage and infections by multi-carbapenemases producing Enterobacterales","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117035"}}